Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
topic_facet:"Recruitment Status: Recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Recruiting%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle
PubPharm (3.166)
1
A first-in-human study evaluating the safety of AXA-042 as a single agent in patients with advanced solid tumors : A Phase 1, first-in-human, open-label, non-randomized, multicenter, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AXA-042 as monotherapy in subjects with advanced solid tumors.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A First-in-Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients With Advanced Tumors : A Phase I, Open-label, Multicenter, First in Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients with Advanced Malignancies
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A study to evaluate an mRNA COVID-19 vaccine (IN002.5.1) in comparison with an approved mRNA COVID-19 vaccine : A randomized, double-blind, active-controlled, phase I clinical study to evaluate the safety, tolerability, and immunogenicity of a COVID-19 mRNA vaccine (in002.5.1) in comparison with an approved mRNA booster vaccine for COVID-19 in population >= 18 years of age
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of OLX72021 in Healthy Males with Androgenetic Alopecia. : A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of OLX72021 in Healthy Males with Androgenetic Alopecia.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Study of ELVN-002 in Healthy Adult Volunteers: Part C : A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ELVN-002 in Healthy Adult Volunteers: Part C Open-label Drug-Drug Interaction
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A first-in-human study evaluating the safety of AXA-042 as a single agent in patients with advanced solid tumors : A Phase 1, first-in-human, open-label, non-randomized, multicenter, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AXA-042 as monotherapy in subjects with advanced solid tumors.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A First-in-Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients With Advanced Tumors : A Phase I, Open-label, Multicenter, First in Human Study to Evaluate the Safety and Tolerability of HH3806 in Patients with Advanced Malignancies
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A study to evaluate an mRNA COVID-19 vaccine (IN002.5.1) in comparison with an approved mRNA COVID-19 vaccine : A randomized, double-blind, active-controlled, phase I clinical study to evaluate the safety, tolerability, and immunogenicity of a COVID-19 mRNA vaccine (in002.5.1) in comparison with an approved mRNA booster vaccine for COVID-19 in population >= 18 years of age
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of OLX72021 in Healthy Males with Androgenetic Alopecia. : A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of OLX72021 in Healthy Males with Androgenetic Alopecia.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study of ELVN-002 in Healthy Adult Volunteers: Part C : A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ELVN-002 in Healthy Adult Volunteers: Part C Open-label Drug-Drug Interaction
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[317]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 1
Filter aufheben
Thema: Recruitment Status: Recruiting
Medienart
3.166
Aufsätze
3.166
E-Artikel
3.166
E-Ressourcen
Zeitschriftentitel
3.166
WHO International Clinical Trials Registry Plat...
Thema
3.166
610
Phase: Phase 1
Recruitment Status: Recruiting
2.578
Study Type: Interventional
408
Study Type: Observational
52
Medical Condition: ;Not Applicable
42
Study Type: Treatment study
40
Medical Condition: ;Neoplasms
40
Medical Condition: Healthy volunteers Not Appli...
34
Study Type: Relative factors research
28
Medical Condition: ;Diseases of the circulatory...
20
Medical Condition: ;Diseases of the nervous system
20
Study Type: Cause
18
Study Type: Prognosis study
16
Medical Condition: Breast cancer
16
Study Type: Diagnostic test
14
Study Type: Prevention
12
Medical Condition: NA
10
Medical Condition: ;Diseases of th respiratory ...
10
Medical Condition: ;Diseases of the digestive s...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.874
2020-
1.292
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
3.132
Englisch
34
Unbestimmt
Haven't found what you're looking for?
Wird geladen...